Clinical Trials Browser

Phase 2 × INDUSTRY × Metastatic Pancreatic Ductal Adenocarcinoma × Clear all

NCT05630183 2025-11-13

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma